NO117626B - - Google Patents

Download PDF

Info

Publication number: NO117626B
Authority: NO; Norway
Prior art keywords: vaccine; poliomyelitis; virus; potential; vaccines
Prior art date: 1966-07-23

Application number

NO16911467A

Other languages

English (en)

Norwegian (no)

Inventor

H Herzog

H Frey

Original Assignee

Dynamit Nobel Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1966-07-23

Filing date

1967-07-20

Publication date

1969-09-01

1967-07-20 Application filed by Dynamit Nobel Ag filed Critical Dynamit Nobel Ag

1969-09-01 Publication of NO117626B publication Critical patent/NO117626B/no

Links

241000700605 Viruses Species 0.000 claims description 40
208000000474 Poliomyelitis Diseases 0.000 claims description 24
238000000034 method Methods 0.000 claims description 18
229960001539 poliomyelitis vaccine Drugs 0.000 claims description 17
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims description 15
239000000243 solution Substances 0.000 claims description 12
230000000890 antigenic effect Effects 0.000 claims description 7
239000007864 aqueous solution Substances 0.000 claims description 4
229960005486 vaccine Drugs 0.000 description 46
238000002360 preparation method Methods 0.000 description 21
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 15
238000003860 storage Methods 0.000 description 13
239000013068 control sample Substances 0.000 description 7
RTKIYNMVFMVABJ-UHFFFAOYSA-L thimerosal Chemical compound [Na+].CC[Hg]SC1=CC=CC=C1C([O-])=O RTKIYNMVFMVABJ-UHFFFAOYSA-L 0.000 description 7
229940033663 thimerosal Drugs 0.000 description 7
241000233866 Fungi Species 0.000 description 6
210000002966 serum Anatomy 0.000 description 6
241000894006 Bacteria Species 0.000 description 5
241000282693 Cercopithecidae Species 0.000 description 5
210000004027 cell Anatomy 0.000 description 5
239000000706 filtrate Substances 0.000 description 5
208000015181 infectious disease Diseases 0.000 description 5
230000002458 infectious effect Effects 0.000 description 5
238000004519 manufacturing process Methods 0.000 description 5
239000000047 product Substances 0.000 description 4
230000000717 retained effect Effects 0.000 description 4
238000011282 treatment Methods 0.000 description 4
102000004142 Trypsin Human genes 0.000 description 3
108090000631 Trypsin Proteins 0.000 description 3
201000010099 disease Diseases 0.000 description 3
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
239000000203 mixture Substances 0.000 description 3
238000004806 packaging method and process Methods 0.000 description 3
239000003755 preservative agent Substances 0.000 description 3
230000002335 preservative effect Effects 0.000 description 3
239000000523 sample Substances 0.000 description 3
238000003756 stirring Methods 0.000 description 3
239000012588 trypsin Substances 0.000 description 3
DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 2
239000000427 antigen Substances 0.000 description 2
102000036639 antigens Human genes 0.000 description 2
108091007433 antigens Proteins 0.000 description 2
210000004369 blood Anatomy 0.000 description 2
239000008280 blood Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000011109 contamination Methods 0.000 description 2
238000010790 dilution Methods 0.000 description 2
239000012895 dilution Substances 0.000 description 2
239000011521 glass Substances 0.000 description 2
230000002779 inactivation Effects 0.000 description 2
239000007788 liquid Substances 0.000 description 2
WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 2
108090000623 proteins and genes Proteins 0.000 description 2
102000004169 proteins and genes Human genes 0.000 description 2
210000005084 renal tissue Anatomy 0.000 description 2
239000004289 sodium hydrogen sulphite Substances 0.000 description 2
235000010267 sodium hydrogen sulphite Nutrition 0.000 description 2
210000001519 tissue Anatomy 0.000 description 2
241000282560 Macaca mulatta Species 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
101100388690 Plasmodium falciparum (isolate K1 / Thailand) MEF-1 gene Proteins 0.000 description 1
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
230000002411 adverse Effects 0.000 description 1
TWJVNKMWXNTSAP-UHFFFAOYSA-N azanium;hydroxide;hydrochloride Chemical compound [NH4+].O.[Cl-] TWJVNKMWXNTSAP-UHFFFAOYSA-N 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
230000002089 crippling effect Effects 0.000 description 1
230000006378 damage Effects 0.000 description 1
230000001419 dependent effect Effects 0.000 description 1
238000007865 diluting Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000000694 effects Effects 0.000 description 1
210000002919 epithelial cell Anatomy 0.000 description 1
125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 1
238000002474 experimental method Methods 0.000 description 1
239000012530 fluid Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
238000002649 immunization Methods 0.000 description 1
230000003053 immunization Effects 0.000 description 1
238000011534 incubation Methods 0.000 description 1
230000036512 infertility Effects 0.000 description 1
238000002347 injection Methods 0.000 description 1
239000007924 injection Substances 0.000 description 1
210000003734 kidney Anatomy 0.000 description 1
210000003292 kidney cell Anatomy 0.000 description 1
239000000463 material Substances 0.000 description 1
229940100892 mercury compound Drugs 0.000 description 1
150000002731 mercury compounds Chemical class 0.000 description 1
244000005700 microbiome Species 0.000 description 1
238000002156 mixing Methods 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
229910052757 nitrogen Inorganic materials 0.000 description 1
IJGRMHOSHXDMSA-UHFFFAOYSA-N nitrogen Substances N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 1
229960005030 other vaccine in atc Drugs 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
238000004321 preservation Methods 0.000 description 1
230000000135 prohibitive effect Effects 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
230000003068 static effect Effects 0.000 description 1
239000000126 substance Substances 0.000 description 1
239000000725 suspension Substances 0.000 description 1
238000004448 titration Methods 0.000 description 1
230000003612 virological effect Effects 0.000 description 1

Classifications

- C—CHEMISTRY; METALLURGY
- C06—EXPLOSIVES; MATCHES
- C06B—EXPLOSIVES OR THERMIC COMPOSITIONS; MANUFACTURE THEREOF; USE OF SINGLE SUBSTANCES AS EXPLOSIVES
- C06B25/00—Compositions containing a nitrated organic compound
- C06B25/18—Compositions containing a nitrated organic compound the compound being nitrocellulose present as 10% or more by weight of the total composition
- C06B25/20—Compositions containing a nitrated organic compound the compound being nitrocellulose present as 10% or more by weight of the total composition with a non-explosive or a non-explosive or a non-thermic component
- C—CHEMISTRY; METALLURGY
- C06—EXPLOSIVES; MATCHES
- C06B—EXPLOSIVES OR THERMIC COMPOSITIONS; MANUFACTURE THEREOF; USE OF SINGLE SUBSTANCES AS EXPLOSIVES
- C06B23/00—Compositions characterised by non-explosive or non-thermic constituents
- C06B23/002—Sensitisers or density reducing agents, foam stabilisers, crystal habit modifiers
- C06B23/004—Chemical sensitisers

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Dental Preparations (AREA)

NO16911467A 1966-07-23 1967-07-20 NO117626B (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DED0050669		1966-07-23

Publications (1)

Publication Number	Publication Date
NO117626B true NO117626B (fr)	1969-09-01

Family

ID=7052828

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO16911467A NO117626B (fr)	1966-07-23	1967-07-20

Country Status (5)

Country	Link
BE (1)	BE701725A (fr)
DE (1)	DE1571218A1 (fr)
GB (1)	GB1170695A (fr)
NL (1)	NL6710138A (fr)
NO (1)	NO117626B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB2193491B (en) *	1978-07-21	1988-09-14	Imi Kynoch Limited Kynoch Work	Improvements in propellants
GB2246348B (en) *	1986-07-15	1993-03-03	Ici Plc	Nitrocellulose propellant composition
DE19907809C2 (de) *	1999-02-24	2002-10-10	Nitrochemie Gmbh	Verfahren zur Herstellung von ein-, zwei- oder dreibasigen Triebladungspulvern für Rohrwaffenmunition

1966
- 1966-07-23 DE DE19661571218 patent/DE1571218A1/de active Pending
1967
- 1967-07-20 NO NO16911467A patent/NO117626B/no unknown
- 1967-07-21 NL NL6710138A patent/NL6710138A/xx unknown
- 1967-07-21 GB GB3378267A patent/GB1170695A/en not_active Expired
- 1967-07-24 BE BE701725D patent/BE701725A/xx unknown

Also Published As

Publication number	Publication date
NL6710138A (fr)	1968-01-24
DE1571218A1 (de)	1970-11-26
GB1170695A (en)	1969-11-12
BE701725A (fr)	1968-01-02

Publication	Publication Date	Title
Koch et al.	1960	Quantitative studies on the infectivity of ribonucleic acid from partially purified and highly purified poliovirus preparations
DE3486292T2 (de)	1994-06-30	Tierärztliche Impfstoffe.
Conant et al.	1968	Rhinoviruses: Basis for a Numbering System: 1. HeLa Cells for Propagation and Serologic Procedures
Yanamura et al.	1941	Studies on the virus of psittacosis cultivated in vitro
US3520972A (en)	1970-07-21	Feline virus vaccines obtained by propagation and serial passage attenuation of virulent feline viruses in diploid feline embryo tissue cell serial passage subculture strains
US3501770A (en)	1970-03-17	Shipping fever vaccine
Brown et al.	1959	The" toxic" activity of vaccinia virus in tissue culture
Gugerell et al.	2019	Viral safety of APOSECTM: a novel peripheral blood mononuclear cell derived-biological for regenerative medicine
Sullivan et al.	1971	Thermal resistance of certain oncogenic viruses suspended in milk and milk products
NO117626B (fr)	1969-09-01
Drake et al.	1952	Effect of nitrogen mustard on virus of serum hepatitis in whole blood.
EP0011864A1 (fr)	1980-06-11	Souche atténuée du virus de la péritonite infectieuse des félins, procédé pour sa préparation et vaccin la contenant
US3709782A (en)	1973-01-09	Heteroploid cell lines
US3097140A (en)	1963-07-09	Preparing a mixed polio, pertussis, tetanus, and diphtheria vaccine with benzethonium chloride
US4021302A (en)	1977-05-03	Cell cultures
Evans et al.	1977	Disinfection of animal viruses
McGAVING	1987	Inactivation of canine parvovirus by disinfectants and heat
US4886779A (en)	1989-12-12	Inactivation of human immunodeficiency virus (HIV) in protein-containing solutions by phenols
US2705696A (en)	1955-04-05	Production of antigens
Beasley et al.	1961	Studies on latent infections of tissue cultures with dengue virus: I. Characteristics of the system
Gardner et al.	1942	Transformation of rabbit fibroma virus (Shope) into infectious myxomatosis (Sanarelli)
RU2290205C1 (ru)	2006-12-27	Способ получения живой вакцины для профилактики гриппа
CN107475204A (zh)	2017-12-15	一种囊膜病毒保护剂及其制备方法
US6403363B1 (en)	2002-06-11	Method of preservation of vaccines with polybiguanide
JP4132151B2 (ja)	2008-08-13	プリオンの不活化方法